Vistin Pharma ASA (FRA:VP4)

Market Cap	84.16M -5.7%
Revenue (ttm)	38.21M +5.3%
Net Income	6.32M +19.1%
EPS	0.14 +19.1%
Shares Out	n/a
PE Ratio	13.32
Forward PE	n/a
Dividend	0.11 (5.97%)
Ex-Dividend Date	Jun 4, 2025

Volume	n/a
Average Volume	n/a
Open	1.815
Previous Close	1.820
Day's Range	1.815 - 1.815
52-Week Range	1.710 - 2.100
Beta	n/a
RSI	51.15
Earnings Date	Feb 12, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1969
• Employees: 73
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VP4

Financial Performance

In 2025, Vistin Pharma ASA's revenue was 452.29 million, an increase of 5.31% compared to the previous year's 429.50 million. Earnings were 74.76 million, an increase of 19.13%.

Financial numbers in NOK